Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.91 +0.03 (+3.22%)
As of: Oct 21, 2026 · 3:53 PM EDT

Phio Pharmaceuticals (PHIO) Capital Leases (2011 - 2012)

Updated

Phio Pharmaceuticals' Capital Leases came in at $5,000 for Q2 2012, unchanged from the prior quarter.

Analysis

Phio Pharmaceuticals (PHIO) Capital Leases (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Phio Pharmaceuticals 10.57 Mn -51.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2012 5,000.00
Mar 31, 2012 5,000.00
Dec 31, 2011 5,000.00
API Access

Phio Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=PHIO&period=max&api_key=YOUR_API_KEY